These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 31635791)
1. Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder. Burghardt KJ; Howlett BH; Sanders E; Dass SE; Msallaty Z; Mallisho A; Seyoum B; Yi Z Eur Neuropsychopharmacol; 2019 Dec; 29(12):1365-1373. PubMed ID: 31635791 [TBL] [Abstract][Full Text] [Related]
2. Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder. Burghardt KJ; Seyoum B; Dass SE; Sanders E; Mallisho A; Yi Z Pharmacotherapy; 2018 Apr; 38(4):428-435. PubMed ID: 29484683 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder. Burghardt KJ; Goodrich JM; Dolinoy DC; Ellingrod VL Epigenomics; 2015; 7(3):343-52. PubMed ID: 26077424 [TBL] [Abstract][Full Text] [Related]
4. DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder. Houtepen LC; van Bergen AH; Vinkers CH; Boks MP Epigenomics; 2016 Feb; 8(2):197-208. PubMed ID: 26792232 [TBL] [Abstract][Full Text] [Related]
5. Decreased global methylation in patients with bipolar disorder who respond to lithium. Huzayyin AA; Andreazza AC; Turecki G; Cruceanu C; Rouleau GA; Alda M; Young LT Int J Neuropsychopharmacol; 2014 Apr; 17(4):561-9. PubMed ID: 24345589 [TBL] [Abstract][Full Text] [Related]
8. DNA redox modulations and global DNA methylation in bipolar disorder: Effects of sex, smoking and illness state. Ceylan D; Scola G; Tunca Z; Isaacs-Trepanier C; Can G; Andreazza AC; Young LT; Özerdem A Psychiatry Res; 2018 Mar; 261():589-596. PubMed ID: 29407727 [TBL] [Abstract][Full Text] [Related]
9. Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia. Flowers SA; Baxter NT; Ward KM; Kraal AZ; McInnis MG; Schmidt TM; Ellingrod VL Pharmacotherapy; 2019 Feb; 39(2):161-170. PubMed ID: 30620405 [TBL] [Abstract][Full Text] [Related]
10. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review. Burghardt KJ; Khoury AS; Msallaty Z; Yi Z; Seyoum B Pharmacotherapy; 2020 Apr; 40(4):331-342. PubMed ID: 32058614 [TBL] [Abstract][Full Text] [Related]
12. Profiling the Skeletal Muscle Proteome in Patients on Atypical Antipsychotics and Mood Stabilizers. Burghardt KJ; Calme G; Caruso M; Howlett BH; Sanders E; Msallaty Z; Mallisho A; Seyoum B; Qi YA; Zhang X; Yi Z Brain Sci; 2022 Feb; 12(2):. PubMed ID: 35204022 [TBL] [Abstract][Full Text] [Related]
13. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. Torrent C; Martinez-Arán A; Daban C; Amann B; Balanzá-Martínez V; del Mar Bonnín C; Cruz N; Franco C; Tabarés-Seisdedos R; Vieta E Compr Psychiatry; 2011; 52(6):613-22. PubMed ID: 21295774 [TBL] [Abstract][Full Text] [Related]
14. The use of atypical antipsychotics in French psychiatric hospitals. Bret MC; Bret P; Pariente A; Fourier-Réglat A Pharm World Sci; 2007 Oct; 29(5):551-6. PubMed ID: 17638111 [TBL] [Abstract][Full Text] [Related]
15. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis. Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157 [TBL] [Abstract][Full Text] [Related]
17. Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic. Patel NC; Crismon ML; Pondrom M J Behav Health Serv Res; 2005; 32(4):438-45. PubMed ID: 16215452 [TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Abdolmaleky HM; Cheng KH; Faraone SV; Wilcox M; Glatt SJ; Gao F; Smith CL; Shafa R; Aeali B; Carnevale J; Pan H; Papageorgis P; Ponte JF; Sivaraman V; Tsuang MT; Thiagalingam S Hum Mol Genet; 2006 Nov; 15(21):3132-45. PubMed ID: 16984965 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder. Abdolmaleky HM; Pajouhanfar S; Faghankhani M; Joghataei MT; Mostafavi A; Thiagalingam S Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):687-96. PubMed ID: 26285059 [TBL] [Abstract][Full Text] [Related]
20. Weight gain with add-on second-generation antipsychotics in bipolar disorder: a naturalistic study. Najar H; Joas E; Kardell M; Pålsson E; Landén M Acta Psychiatr Scand; 2017 Jun; 135(6):606-611. PubMed ID: 28407229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]